See also this year's filing and all EDGAR filings for this company.
PDF Report 0001492422_2019_Apellis_Pharmaceuticals_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001492422')"} |
Graph
Absolute values for 0001492422, Apellis Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 202,439,221 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,094,338 |
| 4 | LiabilitiesCurrent | 17,024,607 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 25,536,297 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 2,427,447 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -125,074,747 |
| 13 | remainder_ComprehensiveNetIncome | -122,807 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 203,533,559 |
| 1 | Liabilities | 42,560,904 |
| 2 | Expenses | 2,427,447 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 160,972,655 |
| 5 | NetIncome | -127,502,194 |
| 6 | ComprehensiveNetIncome | -127,563,598 |
| 7 | BaseVar | 186,859,732 |
| 8 | EconomicCapitalRatio | 1.21 |
Edgar->Model Mapping
Feature Distribution
Change over Time
